跳至主要内容
临床试验/NCT06223906
NCT06223906招募中不适用

A Registry Study of Biomarkers in Heart Valve Disease

Beijing Institute of Heart, Lung and Blood Vessel Diseases1 个研究点 分布在 1 个国家目标入组 200,000 人开始时间: 2016年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200,000
试验地点
1
主要终点
All-cause death

研究概览

简要总结

Valvular Heart Disease, impacting 2.5% of the population, is predominantly observed in the elderly and is on the rise. The primary conditions within this category are Aortic Stenosis and Mitral Regurgitation. These conditions are linked to considerable morbidity and mortality, presenting a formidable challenge in optimizing treatment strategies. Pathophysiology of Valvular Heart Disease remains poorly known. The aim of the present study is to identify biomarkers involved in this disease using multi-omics approaches

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients clinically diagnosed with heart valve disease in Beijing Anzhen Hospital

排除标准

  • Age < 18 years
  • Failure to obtain medical records and ultrasound data
  • Refuse follow-up

结局指标

主要结局

All-cause death

时间窗: These data is collected during follow-up visit at 12 months after discharge

whether recidivation happened,whether other related disease happened

次要结局

  • HF rehospitalization(These data is collected during follow-up visit at 12 months after discharge)

研究者

发起方
Beijing Institute of Heart, Lung and Blood Vessel Diseases
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Registry Study of Biomarkers in Heart Valve Disease | 临床试验